_id

690daf39ccc777a4e85d0aec

Ticker

ANTX

Name

AN2 Therapeutics Inc

Exchange

NASDAQ

Address

1800 El Camino Real, Menlo Park, CA, United States, 94027

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.an2therapeutics.com

Description

AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials; and has various research programs targeting the development of novel compounds in oncology and infectious disease based on its boron chemistry platform. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize compounds and products, including epetraborole for the treatment, diagnosis, or prevention of various human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize compounds and products comprising epetraborole in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases; and GSK plc for the development of new therapies for TB. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Last Close

1.2

Volume

46087

Current Price

1.17

Change

-2.500000000000002

Last Updated

2025-11-28T12:15:45.762Z

Image

-

Ipo Date

2022-03-25T00:00:00.000Z

Market Cap

29046144

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-0.318

Sentiment Sources

1

Rating

2.6667

Target Price

1.5

Strong Buy

0

Buy

1

Hold

1

Sell

0

Strong Sell

1

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

10040000

Operating Income

-10040000

Interest Expense

-

Pretax Income

-9353000

Net Income

-9353000

Eps

-0.30892221389519103

Dividends Per Share

-

Shares Outstanding

27402024

Income Tax Expense

-

EBITDA

-9353000

Operating Margin

-

Total Other Income Expense Net

687000

Cash

18003000

Short Term Investments

43918000

Receivables

-

Inventories

-

Total Current Assets

64016000

Property Plant Equipment

-

Total Assets

67235000

Payables

2226000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

6858000

Equity

60377000

Depreciation

-

Change In Working Capital

2388000

Cash From Operations

-6375000

Capital Expenditures

0

Cash From Investing

6110000

Cash From Financing

48000

Net Change In Cash

-217000

PE

-

PB

0.6017436441028868

ROE

-15.490998227801978

ROA

-13.91090949654198

FCF

-6375000

Fcf Percent

-

Piotroski FScore

1

Health Score

42

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

6.5

Quality Investing Score

2.5

Value Investing Score

6.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

10040000

Quarters > 0 > income Statement > operating Income

-10040000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-9353000

Quarters > 0 > income Statement > net Income

-9353000

Quarters > 0 > income Statement > eps

-0.30892221389519103

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

30276230

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-9353000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

687000

Quarters > 0 > balance Sheet > cash

18003000

Quarters > 0 > balance Sheet > short Term Investments

43918000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

64016000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

67235000

Quarters > 0 > balance Sheet > payables

2226000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

6858000

Quarters > 0 > balance Sheet > equity

60377000

Quarters > 0 > cash Flow > net Income

-9353000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

2388000

Quarters > 0 > cash Flow > cash From Operations

-6375000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

6110000

Quarters > 0 > cash Flow > cash From Financing

48000

Quarters > 0 > cash Flow > net Change In Cash

-217000

Quarters > 0 > ratios > PE

-0.30892221389519103

Quarters > 0 > ratios > PB

0.6017436441028868

Quarters > 0 > ratios > ROE

-15.490998227801978

Quarters > 0 > ratios > ROA

-13.91090949654198

Quarters > 0 > ratios > FCF

-6375000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

7216000

Quarters > 1 > income Statement > operating Income

-7216000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-6462000

Quarters > 1 > income Statement > net Income

-6462000

Quarters > 1 > income Statement > eps

-0.21416975183353434

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

30172328

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-7216000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

754000

Quarters > 1 > balance Sheet > cash

18220000

Quarters > 1 > balance Sheet > short Term Investments

44696000

Quarters > 1 > balance Sheet > receivables

2700000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

67524000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

75825000

Quarters > 1 > balance Sheet > payables

2113000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

6983000

Quarters > 1 > balance Sheet > equity

68842000

Quarters > 1 > cash Flow > net Income

-6462000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-2836000

Quarters > 1 > cash Flow > cash From Operations

-7599000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

5834000

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-1765000

Quarters > 1 > ratios > PE

-0.21416975183353434

Quarters > 1 > ratios > PB

0.525940466575637

Quarters > 1 > ratios > ROE

-9.386711600476454

Quarters > 1 > ratios > ROA

-8.522255192878339

Quarters > 1 > ratios > FCF

-7599000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

41

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

11537000

Quarters > 2 > income Statement > operating Income

-11537000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-10649000

Quarters > 2 > income Statement > net Income

-10649000

Quarters > 2 > income Statement > eps

-0.3543288746922207

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

30054000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-11537000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

888000

Quarters > 2 > balance Sheet > cash

19985000

Quarters > 2 > balance Sheet > short Term Investments

47075000

Quarters > 2 > balance Sheet > receivables

300000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

69559000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

81343000

Quarters > 2 > balance Sheet > payables

3073000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

8014000

Quarters > 2 > balance Sheet > equity

73329000

Quarters > 2 > cash Flow > net Income

-10649000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-1579000

Quarters > 2 > cash Flow > cash From Operations

-10624000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

9193000

Quarters > 2 > cash Flow > cash From Financing

65000

Quarters > 2 > cash Flow > net Change In Cash

-1366000

Quarters > 2 > ratios > PE

-0.3543288746922207

Quarters > 2 > ratios > PB

0.4918217894693777

Quarters > 2 > ratios > ROE

-14.522221767649906

Quarters > 2 > ratios > ROA

-13.091476832671528

Quarters > 2 > ratios > FCF

-10624000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

8598000

Quarters > 3 > income Statement > operating Income

-8598000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-7522000

Quarters > 3 > income Statement > net Income

-7522000

Quarters > 3 > income Statement > eps

-0.25171502191881673

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

29883000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7522000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1076000

Quarters > 3 > balance Sheet > cash

21351000

Quarters > 3 > balance Sheet > short Term Investments

62267000

Quarters > 3 > balance Sheet > receivables

300000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

86262000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

92087000

Quarters > 3 > balance Sheet > payables

3317000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

10238000

Quarters > 3 > balance Sheet > equity

81849000

Quarters > 3 > cash Flow > net Income

-7522000

Quarters > 3 > cash Flow > depreciation

8607000

Quarters > 3 > cash Flow > change In Working Capital

1036000

Quarters > 3 > cash Flow > cash From Operations

-5273000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-6880000

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

-12153000

Quarters > 3 > ratios > PE

-0.25171502191881673

Quarters > 3 > ratios > PB

0.4381189751860133

Quarters > 3 > ratios > ROE

-9.190093953499737

Quarters > 3 > ratios > ROA

-8.168362526741017

Quarters > 3 > ratios > FCF

-5273000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

42

Valuation > metrics > PE

-0.30892221389519103

Valuation > metrics > PB

0.6017436441028868

Valuation > final Score

70

Valuation > verdict

39.8% Undervalued

Profitability > metrics > ROE

-15.490998227801978

Profitability > metrics > ROA

-14.610409897525619

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1135862994186528

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

28.758310871518418

Liquidity > metrics > Quick Ratio

28.758310871518418

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

22

Prev Risks > 1

8

Prev Risks > 2

80

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T11:44:16.067Z